Since the discovery of an interaction between membrane transport proteins and the mammalian STE20 (sterile 20)-like kinases SPAK (STE20/SPS1-related proline/alanine-rich kinase) and OSR1 (oxidative stress-responsive kinase-1), a significant body of work has been performed probing the molecular physiology of these two kinases. To date, the function of SPAK and OSR1 is probably the best known of all mammalian kinases of the STE20 family. As they regulate by direct phosphorylation key ion transport mechanisms involved in fluid and ion homoeostasis, SPAK and OSR1 constitute key end-of-pathway effectors. Their significance in such fundamental functions as ion homoeostasis and cell volume control is evidenced by the evolutionary pressure that resulted in the duplication of the OSR1 gene in higher vertebrates. This review examines the distribution of these two kinases in the animal kingdom and tissue expression within a single organism. It also describes the main molecular features of these two kinases with emphasis on the interacting domain located at their extreme C-terminus. A large portion of the present review is devoted to the extensive biochemical and physiological studies that have resulted in our current understanding of SPAK/OSR1 function. Finally, as our understanding is a work in progress, we also identify unresolved questions and controversies that warrant further investigation.
INTRODUCTION
The present review focuses on two closely related mammalian protein kinases, SPAK [STE20 (sterile 20)/SPS1-related proline/ alanine-rich kinase] and OSR1 (oxidative stress-responsive kinase-1), members of the STE20 superfamily of MAPK (mitogen-activated protein kinase)-like protein kinases. The first protein SPAK [1] , also known as PASK in rat [2] and STK39 in GenBank ® , was first identified as a novel kinase in a pancreatic β-cell PCR screen that used degenerate oligonucleotide primers to amplify fragments from catalytic subdomains VIb and IX of protein kinases [3] . The second protein, OSR1, was identified as part of a large-scale DNA sequencing of a region of human chromosome 3 designed to find tumour suppressor genes [4] . SPAK and OSR1 share high amino acid sequence homology in both their N-terminal catalytic domain (96 %), and their C-terminal regulatory domain (67 %). Amino acid sequence alignment from 14 different species indicates that OSR1 is the prototypical kinase and that SPAK has evolved from gene duplication during vertebrate evolution. To date, there are 25 sequences of OSR1 and SPAK in GenBank ® , all found in organisms higher in evolution than Plathyelminthes (flatworms). As several flatworm genome projects are underway, one waits to see whether these organisms express kinases with OSR1/SPAK features. Currently there is no kinase with OSR1 features that can be identified in the plant genomes Arabidopsis thaliana (thale cress), Oryza sativa (rice) and Populus trichocarpa (black cottonwood). To date, GenBank ® contains 20 OSR1 sequences (from roundworm to human) and 7 SPAK sequences (from chicken to human). A phylogenetic tree representation is shown in Figure 1 .
Following the sequencing of the entire human genome, 518 protein kinases were identified and catalogued into 134 families and 201 subfamilies [5] . This diversity, within one single genome stresses the significance of this mode of post-translational modification as a way to modulate protein function. Despite this protein diversity, their common mode of action and highly conserved catalytic domains indicate that most typical eukaryotic protein kinases are likely to be traced back to one or a few common ancestors. Interestingly, for the purpose of the present review, phylogenetic tree analysis of all human kinase domains placed the family of WNKs [with no K (lysine) protein kinases] closest to the STE20 superfamily of protein kinases [5] . In fact, there is some puzzling homology that can be found between WNKs and SPAK/OSR1 outside of the catalytic domain. Figure 2 illustrates the conservation between a portion of the auto-inhibitory domain of WNK1 [6] , and a portion of the interacting domain of SPAK/OSR1 [7] . Indeed, the stretch of 41 residues shares 22.0 % identity and 95.1 % conservation between the WNKs and SPAK and OSR1. The significance of this sequence similarity has not yet been addressed, but is puzzling in light of the fact that the peptides belong to domains of different attributed functions, autoinhibitory in one case and scaffolding in the other. Note however that protein-protein interaction constitutes a common feature Abbreviations used: AATYK, apoptosis-associated tyrosine kinase; CCC, cation-chloride co-transporter; CCT, conserved C-terminal; COX-2, cyclooxygenase-2; ERK, extracellular-signal-regulated kinase; GCK, germinal centre kinase; HEK, human embryonic kidney; JNK, c-Jun N-terminal kinase; KCC, K + -Cl − co-transporter; MAPK, mitogen-activated protein kinase; MAP2K, MAPK kinase; MAP3K, MAPK kinase kinase; MAP4K, MAPK kinase kinase kinase; MEK, MAPK/ERK kinase; NKCC, Na + -K + -2Cl − co-transporter; OSR1, oxidative stress-responsive kinase-1; PAK1, p21-activated kinase 1; RELT, receptor expressed in lymphoid tissues; SPAK, STE20/SPS1-related proline/alanine-rich kinase; STE20, sterile 20; TAO, thousand-and-one amino acid kinase; TNF, tumour necrosis factor; WNK, with no K (lysine) protein kinase. 1 To whom correspondence should be addressed (email eric.delpire@vanderbilt.edu).
Figure 1 Cluster dendogram of the members of GCK-VI subfamily of STE20p-related kinases
Amino acid sequences of 27 proteins were aligned before computing the cluster dendrogram. The dendrogram was drawn using the Drawtree program from the PHYLIP software package (PHYLogeny Inference Package, University of Washington). The OSR1 sequences are from roundworm (C. elegans; NP_507517), fruit fly (Drosophila melanogaster; NP_477308), mosquito (Ades aegypti; EAT36321), mosquito (Anopheles gambiae; EAA04686), honey bee (Apis mellifera; XP_396480), sea urchin (Strongylocentrotus purpuratus; XP_791076), zebrafish (Danio rerio; AAH67372), pufferfish (Tetraodon nigroviridis; CAF97685), African claw frog (Xenopus laevis; AAH77748), pipid frog (Xenopus tropicalis; AAH67933), chicken (Gallus gallus; XP_418527), mouse (Mus musculus; Q6P9R2), rat (Rattus norvegicus; NP_963854), dog (Canis familiaris; XP_859626), pig (Sus scrofa; Q863I2), horse (Equus caballus; XP_001488478), macaque (Macaca mulatta; XP_001087567), chimpanzee (Pan troglodytes; XP_526174) and human (Homo sapiens; NP_005100). The SPAK sequences are from chicken (Gallus gallus; XP_422019), mouse (Mus musculus; NP_058562), rat (Rattus norvegicus; NP_062235), dog (Canis familiaris; XP_535944), macaque (Macaca mulatta; XP_001102299), chimpanzee (Pan troglodytes; XP_515880) and human (Homo sapiens; NP_037365).
Figure 2 Homologous regions between WNK and SPAK/OSR1
A 41 bp fragment of the C-terminal-interacting domain of SPAK and the autoinhibitory domain of WNK1 (red box) are highly conserved. Amino acid alignment of mouse sequences shows identical residues in yellow and conserved residues in blue or green. The alignment was performed using VectorNti (Version 6).
of both domains. In fact, the 41 residue peptide constitutes a critical portion of an interacting domain (see below and [8] ). A BLAST search of mammalian proteins with the 41 residue peptide did not identify additional proteins containing this conserved primary amino acid sequence, making the WNK and SPAK/OSR1 connection even more relevant. As we will discuss in a later section, SPAK, OSR1 and WNK are linked functionally as they belong to a common signalling pathway.
FEATURES OF SPAK AND OSR1
Based on phylogenetic relationships, Dan et al. [9] recognized SPAK and OSR1 as two distinct members of the STE20 kinase family, and placed them in a distinct subfamily of GCK (germinal centre kinase)-like kinases: the GCK-VI subfamily. The differentiation was based on their distinct C-terminal tails of 'unknown function' [9] . We now know that these C-terminal domains are
Figure 3 Features of SPAK
The amino acid sequence of mouse SPAK with α-helices (blue boxes) and β-strands (green boxes). The structure of the kinase domain was modelled based on TAO2 and PAK1 crystal structures [10] . The structure of the C-terminus was solved by Villa et al. [8] . Filled and open arrowheads indicate the beginning and end of a sequence missing in the colon isoform (see text). The catalytic domain is defined by two vertical lines. The position of the catalytic loop, Mg 2+ -binding loop, activation loop, P+1 loop, nuclear-localization signal and caspase-cleavage site are also indicated. Asterisks highlight four phospho-threonine residues that are part of SPAK activation. Boxes (shown in pink) highlight the four hydrophobic residues in the F+1 loop which form a hydrophobic pocket attracting the substrate P+1 residue. Key C-terminal residues participating in the binding of the RFxV peptide are also highlighted (see text).
key to the function of these kinases as they anchor their targets for phosphorylation (see below). As a GCK-like kinase, SPAK and OSR1 have their catalytic domains located at the N-terminus and a long regulatory domain located downstream at the C-terminus ( Figure 3 ). In contrast with OSR1 which has only 16 residues upstream of the kinase domain, SPAK contains an upstream stretch of 74 residues. This longer peptide contains a region rich in consecutive alanine and proline residues, referred to as a 'PAPA box'. Functional studies have demonstrated that removal of this domain does not affect the kinase function of SPAK, or its ability to activate its substrates through phosphorylation [10] . In fact, the 'PAPA box' can be missing in some tissues due to the presence of a 5 splice junction-like sequence within exon 1 which results in a shorter exon [11] . The kinase domains of SPAK and OSR1 possess the typical two-domain architecture similar to the kinase domains of other STE20 proteins such as TAO2 (thousand-and-one amino acid kinase 2) [12] and PAK1 (p21-activated kinase 1) [13] . Mutagenesis experiments revealed that Thr 243 and Thr 247 of the activating loop are autophosphorylated and are essential for SPAK function [10] . Furthermore, Thr 243 is a target of phosphorylation by an upstream kinase [14, 15] . The C-terminus of SPAK and OSR1 can be divided into three parts: a highly homologous region containing a putative nuclear localization signal and a caspasecleavage site (DEMDE), a central region of divergence between the two kinases, and a terminal region of high conservation (Figure 3) . Two studies have reported that C-terminally truncated SPAK can be found in the nucleus [2, 11] , suggesting a possible role for the caspase site and for the kinase in apoptosis.
TISSUE DISTRIBUTION OF SPAK AND OSR1
SPAK mRNA transcripts and protein are found abundantly in brain, salivary gland, pancreas, adrenal gland and testis, and to a lesser degree in heart, lung, kidney, stomach, intestine, ovary, thymus and spleen, and skeletal muscle [1, 2, 16] . At the organ/tissue level, expression of OSR1 overlaps with SPAK as mRNA transcripts and protein are also observed in brain, skeletal muscle, kidney, pancreas, testis, heart, lung, intestine, liver, ovary, thymus and spleen [4, 16] . The highest mRNA expression levels are found in heart and skeletal muscle, followed by liver, small intestine and colon [4] . A direct comparison between SPAK and OSR1 expression is difficult as no study has directly compared expression at the mRNA level using similar 32 P-labelled cDNA probes. Furthermore, even if we published the tissue distribution of SPAK and OSR1 [16] using identical protein samples isolated from mouse tissue, the specific characteristics of the SPAK and OSR1 antibodies (i.e binding affinity, titre etc.) are unknown, preventing a direct quantification of kinase expression. However, it is clear that SPAK expression is much more abundant than OSR1 expression in secretory epithelia such as choroid plexus and salivary gland.
During development, expression of SPAK can already be detected by in situ hybridization in early pancreatic and gut tube epithelia of e12 (where e is embryonic day) rat embryos [17] . As the pancreas develops from e15 to e17, expression of the kinase increases in the distal region where the acini form, whereas no expression is observed in the proximal region. Outside of the pancreas, SPAK expression is also high in e14 rat embryos in the choroid plexus, myocardium, mesonephron and dorsal root ganglia [17] .
INTERACTORS OF SPAK AND OSR1
SPAK and OSR1 were both identified as interactors of membraneassociated proteins in yeast two-hybrid screens. SPAK was shown to interact with the CCCs (cation-chloride co-transporters) KCC The position of the conserved arginine and phenylalanine residues is arbitrarily set at +1 and +2 respectively. Boxes indicate conserved residues. Threonine and serine residues at position +5 are highlighted by grey circles. Also note the preponderance of negatively charged residues (bold and underlined) at position +9. Interaction at the first 13 motifs was demonstrated by yeast two-hybrid analysis, whereas interaction at the last four motifs was shown via co-immunoprecipitation (Co-IP).
− co-transporter) 1 and NKCC2 [7] and a TNF (tumour necrosis factor) receptor expressed in lymphoid tissues [18] . The Caenorhabditis elegans orthologue of OSR1, GCK-3, was identified as an interactor of CLH3, a ClC-type chloride channel [19] . Using the C-terminus of SPAK as a bait in a yeast two-hybrid screen, the kinase was later shown to also bind to WNK2, WNK4, gelsolin, AATYK (apoptosis-associated tyrosine kinase), HSP (heat-shock protein) 105 and otoferlin [16] . Using co-immunoprecipitation followed by SDS/PAGE, Coomassie Blue staining and tryptic peptide MS fingerprinting, two groups have independently identified SPAK as an interactor of WNK1 [14, 15] .
We first identified the SPAK-binding site by using deletion mutants of the N-terminus of KCC3 [7] . We showed that nine residues (RFQVTPTKI) located in the N-terminus of KCC3 were sufficient to promote SPAK binding. Using alanine scanning and conservative mutagenesis, we identified a short consensus sequence consisting of a positive charge (an arginine or lysine residue) at position +1, followed by a phenylalanine residue at position +2, any residue at position +3 and a valine or isoleucine residue at position +4. Our yeast two-hybrid experiments demonstrated that five additional residues were also needed for interaction, although no consensus at positions +5-+9 could be found. Thus we proposed the binding motif [R/K]Fx[V/I]xxxxx. Whether the five residues truly participate in the interaction or are a peculiarity of the yeast two-hybrid system is still unknown. Additionally, it is also unknown whether residues located upstream of the positive charge (position +1) are required for this interaction. In the case of KCC3 SPAK binding occurs at the extreme N-terminus as the +1 arginine residue is located eight residues downstream of the start methionine residue.
Alignment The interactive peptide (Gly-Arg-Phe-Gln-Val) is displayed in its binding position. The model was created using Pymol based on the structure mmdb ID: 47336 [8] . [20] . These proteins are distributed into various categories: membrane proteins, cytoskeletal proteins, enzymes, nuclear proteins etc. Because of the wide tissue distribution of SPAK and OSR1, these 130 proteins are good candidates as potential interactors. However, whether or not they actually interact with the STE20 kinases will need to be assessed on a case by case basis.
[S/V/G]RFx[V/I]xx[T/I/S/V]xx motifs located in 130 proteins
Our original yeast two-hybrid studies of SPAK and KCC3 revealed that the last 90 residues of the C-terminus of the kinase interacts with the RFxV motif in the co-transporter [16] . In fact, within the C-terminus, this interacting domain exhibits the highest homology with the corresponding region in the OSR1 C-terminus. The fact that 90 residues are necessary for proteinprotein interaction suggests that the C-terminus forms a large protein fold that accommodates the RFxV peptide. A recent study resolved the structure of this docking domain [termed by the authors the CCT (conserved C-terminal) domain] [8] . The CCT consists of four antiparallel β-strands packed against two large and one small α-helices. Analysis of the molecular surface reveals the presence of a negatively charged primary pocket formed by the interface between α1 and β2 and a secondary hydrophobic pocket formed by the large loop connecting α3 and β4 ( Figure 5 ). The peptide, co-crystallized with the C-terminus of OSR1, constitutes the OSR1-binding site of WNK4 (Gly-Arg-Phe-Ala-Val-Thr). As seen in Figure 5 , it binds to the primary pocket with the +1 arginine residue forming salt bridges with conserved aspartic and glutamic acid residues, which are located 3.0 and 2.8 Å (1 Å = 0.1 nm) away from the arginine residue respectively. The phenylalanine residue of the RFxV motif fits into a hydrophobic pocket formed by hydrophobic residues (Phe 481 , Leu 497 , Ala 499 and Leu 502 ; see Figure 5 ). The role of the second pocket is unknown. It is tempting to speculate that this pocket accommodates the additional five residues shown to be necessary for yeast two-hybrid interaction [7] . The second pocket could conceivably accommodate additional residues from specific proteins and not others, enhancing protein-protein interaction. In fact, the crystal structure indicates that the second pocket is contiguous to the first one and is large enough to accommodate six to seven residues. Interestingly, mutations of conserved hydrophobic residues lining this pocket have little to no effect on WNK1 or NKCC1 binding [8] . Based on the absence of any yeast two-hybrid interactors lacking a RFxV motifs (otoferlin being one possible exception), we speculate that the second hydrophobic pocket is unlikely to constitute a binding site for other protein domains. However, since this speculation is based on negative results, this needs to be tested experimentally.
As indicated in Figure 4 , many SPAK or OSR1 interactors possess a threonine or serine residue at position +5, directly following the valine/isoleucine residue. In their manuscript, Villa et al. [8] presented evidence that the threonine residue in WNK4 (Thr 1000 , mouse sequence numbering) is a phosphothreonine. Phosphorylation of this residue resulted in the loss of protein-protein interaction, suggesting that this might constitute an important site of regulation. At this point, the identity of the kinase phosphorylating this residue is unknown. It is also unknown whether serine or threonine residues located at positions +6-+9 could also affect SPAK or OSR1 binding when phosphorylated. This speculation is relevant when considering that serine residues were predominantly found among all residues located at position +6-+9 within the 137 putative SPAK motifs identified in mouse proteins [20] . Note, however, that in NKCC1 and gelsolin (Figure 4 ), there is a negatively charged residue located at position +5, suggesting that loss of interaction due to phosphorylation of a threonine residue at position +5 might not be related to the negative charges of the phosphate. Binding experiments were performed to measure the ability of the RFxV peptide to bind wild-type or mutant C-terminal OSR1 domains. From these experiments, the binding affinity of the peptide to the pocket was measured at 8 nM [8] .
FUNCTION OF STE20 KINASES
We will approach the biological role of SPAK/OSR1 by first briefly reviewing the function of other STE20p-like kinases. A good place to start would be to examine the function of the budding yeast, STE20p, the parental protein. STE20p participates in a variety of signalling pathways in the yeast cell which includes the pheromone-response pathway [21] , the pseudohyphalgrowth pathway [22] and the osmotic response or HOG (high osmolarity glycerol) pathway [23] . In the pheromone-response pathway, STE20p is closely associated to the pheromone receptor. When activated, the receptor causes the activation of G βγ , transmitting the pheromone signal through STE20p [MAP4K (MAPK kinase kinase kinase)], STE11p [MAP3K (MAPK kinase kinase)], STE7p [MAP2K (MAPK kinase)] and Fus3p (MAPK) to some transcription factors. Activation of the transcription factors ultimately results in the induction of genes that facilitate mating and leads to the arrest of the cells in the G 1 -phase of the cell cycle. This chain of events indicates that the prototypical STE20p kinase is a MAPK involved in signalling. However, signalling through MAPK pathways is not its sole function as STE20p was shown to also directly phosphorylate myosin I, leading to the reorganization of the actin cytoskeleton during yeast budding [24] . This duality in function of STE20p might have been conserved throughout evolution and might be pertinent to mammalian SPAK and OSR1.
One common feature of most mammalian STE20 kinases is their involvement in relaying cellular stress signals. For instance, the PAKs are regulated by the small G-proteins cdc42 and Rac, and participate (among other functions) in cytoskeleton rearrangements that occur upon cellular stresses (filopodia and lamellopodia formation, polymerization of cortical actin and recruitment of cytoskeletal-associated proteins [25] ). Most GCKlike STE20p kinases have been shown to take part in MAPK signalling, either acting as MAP4K or MAP3K [9] . One such example is the activation of MEK [MAPK/ERK (extracellularsignal-regulated kinase) kinase] 3 and MEK6 by TAO1 and TAO2, placing TAO as MAP3K in the activation of the p38 MAPK pathway. In addition, several STE20 kinases are also involved in programmed cell death, cell migration and proliferation [26] .
FUNCTIONS OF SPAK AND OSR1

SPAK association with the cytoskeleton
Fractionation studies from rat brain demonstrated that SPAK partitions into both soluble and Triton X-100 insoluble fractions (i.e. a fraction containing cytoskeletal proteins such as actin and and α-tubulin) [27] . Interestingly, very little SPAK was found in the insoluble fraction of NIH3T3 and PC12 cultured cells under control conditions, whereas an increased amount of SPAK was partitioned in the insoluble fraction under osmotic, oxidative and high-temperature stress. These results indicate translocation of the kinase from the cytosol to the cytoskeleton in response to cellular stress. Interestingly, not all cellular stresses resulted in kinase translocation, for example, only hyperosmotic but not hypo-osmotic stress was effective in increasing Triton insolubility. Experiments with [ 32 P]P i indicated that SPAK was in a phosphorylated state in the cytosol, whereas its association with the insoluble fraction resulted in a decrease in phosphorylation [27] . These results are consistent with activated/phosphorylated SPAK moving from the cytosol to the membrane to phosphorylate and activate transport molecules (see below).
SPAK modulation of ion transport
Based on its interaction with several CCCs [7] and with the chloride channel CLH3 [19] , we believe that SPAK and OSR1 play fundamental roles in regulating epithelial transport. We also believe that the kinases are key components of cellvolume-dependent activation or inhibition of ion transporters and channels. They are indeed effectors located at the end of a chain of events (or signalling) that lead to conformational changes and activity changes of transporters and channels. Consistent with this idea, expression of OSR1 was followed in osmosensing chloride-secreting cells of opercular epithelium and gill of the Killifish as it adapted from seawater to freshwater [28] . OSR1 expression, which co-localized with NKCC1, was higher in tissues taken from freshwater animals, compared with that of similar tissues from seawater animals, suggesting a role for the kinase in osmoregulation. A role for OSR1 in systemic osmoregulation has been recently demonstrated in C. elegans [29] . Indeed, the C. elegans kinase, GCK-3, was shown to be required for RVI (regulatory volume increase) and worm survival after application of hypertonic treatment through addition of NaCl or sorbitol.
As mentioned earlier, WNKs are also involved in SPAK/OSR1 function. The first two papers reporting the molecular cloning of SPAK presented evidence for SPAK co-precipitating an unidentified upstream kinase [1, 2] . Several studies have now identified the upstream kinase as one of the four WNK members [14, 15, 30, 31] . However, which upstream WNK is acting on which STE20 kinase, SPAK or OSR1, probably depends upon the tissue and cell type. For instance, WNK3 is abundant in the brain, and therefore probably plays a significant role in the nervous system. However, similar to the SPAK and OSR expression overlap in many tissues and cell types, the other three WNK gene products are also expressed in the nervous system. Hopefully, in the near future, we will have a precise view of which kinases regulate ion transport in particular cell types. One way this could be achieved would be through experiments involving RNAi (RNA interference) and/or knockout animals. Na
− co-transport promotes the electroneutral, coupled movement of sodium and potassium, together with chloride, through two gene products NKCC1 and NKCC2. Although NKCC2 expression is restricted to the thick ascending limb of Henle of the renal tubule and is a key component of sodium reabsorption [32] , NKCC1 is expressed in a variety of cells where it participates in a variety of functions such as cellvolume regulation [33] , potassium [34, 35] and chloride secretion [36] [37] [38] and chloride homoeostasis in sensory neurons [39, 40] . The importance of Na + -K + -2Cl − co-transport is demonstrated by the fluid and salt wasting disorder associated with an inactivating mutation in human (Bartter syndrome, [41] ) and mouse [42] NKCC2; and by the multitude of phenotypes observed in the NKCC1-knockout mouse (sensorineural deafness [35, 43] , intestinal deficit [43, 44] , male infertility [45] , olfactory [46] and pain perception [40, 47] deficits, tooth decay [48] and low blood pressure [49, 50] ). Na + -K + -2Cl − co-transport is activated by growth hormones and cytokines, as well as oxidative and osmotic stressors [51] . Among the best known activators of NKCC function are a reduction in intracellular chloride concentration [52] and cell shrinkage [53] .
Our working model for NKCC1 activation envisages an upstream WNK phosphorylating and activating SPAK (or OSR1), which in turn phosphorylates and activates the co-transporter NKCC1. This model is based on biochemical data showing the interaction of WNK with SPAK/OSR1 (by yeast two-hybrid [30] and co-immunoprecipitation [15] studies), direct phosphorylation by WNK of specific residues of SPAK (Thr 243 and Ser 383 ; [54] ), and functional data showing an absence of co-transporter activation when WNK4 is unable to interact with SPAK, SPAK is unable to bind to the co-transporter [30] , or SPAK is catalytically inactive [30, 55] . This sequence of events brings the possibility that the three proteins form a complex in vivo. However, NKCC1 activation requires that SPAK anchors to both the N-terminus of NKCC1 and the C-terminus of WNK. Since it is unlikely that the hydrophobic pocket of the SPAK C-terminal can accommodate two RFxV peptides, the only possibility of a complex would be if the STE20 kinase forms a dimer and each monomer binds to a different interacting protein. To date, two laboratories have addressed the issue of SPAK or OSR1 dimerization. On one hand, Anselmo et al. [31] demonstrated that Myc-tagged fulllength OSR1 immunoprecipitated full-length FLAG-tagged OSR1, indicating that the two proteins might oligomerize. By using deletion mutants, they narrowed the site of interaction to the kinase domain, thus eliminating the possibility that proteins containing several RFxV-binding motifs (NKCC1, WNK1 and AATYK) could serve as scaffolds for multiple SPAK/OSR1 molecules in a co-immunoprecipitation experiment. However, there remains the possibility that F-actin [27] complexes multiple SPAK (or OSR1) molecules in an immunoprecipitate. On the other hand, by using yeast two-hybrid analysis, we established that full-length SPAK fused to the activating domain of GAL4 in pACT2 does not interact with full-length SPAK fused to the binding domain of GAL4 in pGBDUc2 [10] . Furthermore, we also showed that one molecule of SPAK failed to phosphorylate the P-loop of another SPAK molecule through an intermolecular reaction. This property is characteristic of kinases, such as MST1 (mammalian STE20-like kinase) [56] , that contain dimerization domains. The discrepancy between the two studies will have to be reconciled. Based on our own results indicating the absence of dimerization, we propose that the binding of SPAK to WNK4 precedes the binding of SPAK to NKCC1 ( Figure 6 ).
As mentioned above, activation of SPAK occurs upon its phosphorylation by WNK at residues Thr 243 and Ser 383 (mouse sequence numbering). Whereas the importance of the activation loop Thr 243 residue was demonstrated by alanine mutagenesis both in in vitro phosphorylation and functional assays [10] , the role of Ser 383 is still unknown. Mutation of this residue into an alanine residue does not affect SPAK activation of the co-transporter (K.B.E. Gagnon and E. Delpire, unpublished work), consistent with the observation that mutation of Ser 383 does not affect SPAK activation by WNK1 [14, 57] .
Based on the results from Tsutsumi et al. [27] , it is tempting to speculate that activated SPAK binds and phosphorylates NKCC1. As NKCC1 contains two SPAK-binding domains in its N-terminal cytosolic tail, we originally inactivated the first domain by mutating the phenylalanine residue of RFxV into an alanine residue and inactivated the second domain by mutating the valine residue into an alanine residue. Based on yeast two-hybrid results, the mutant tail was thought to be unable to interact with NKCC1. However, the mutant co-transporter was still found to be activated by SPAK [30] . Peptide-binding studies performed by Vitari et al. [14] , indicated that some binding was still occurring when the valine residue was mutated into an alanine residue, consistent with our functional data. We have now created a complete SPAKbinding deficient NKCC1 by mutating the two phenylalanine residues into alanine residues and have demonstrated a significant reduction in SPAK phosphorylation in vitro, and an absence of NKCC1 activation in vivo [58] . Thus the requirement for SPAK binding to NKCC1 for SPAK activation of the co-transporter is now settled.
Using MS and Edman sequencing, Darman and Forbush [59] identified three threonine residues in the N-terminal tail of NKCC1 which are phosphorylated upon cell exposure to forskolin [59] . In mouse NKCC1, these residues are Thr 206 , Thr 211 and Thr 224 . Using the same method, Vitari et al. [14] have identified three threonine residues that are targets of SPAK phosphorylation [54] . In mouse NKCC1, these residues are [58] . Only mutations of Thr 206 and Thr 211 , however, had a significant effect on NKCC1 function [58] . Of importance is the observation that Thr 206 is followed by a hydrophobic residue which when mutated into an alanine residue also leads to absence of SPAK activation of NKCC1. The residue, often referred to as the P+1 residue, facilitates the presentation of the threonine residue in an hydrophobic pocket of the kinase. We have shown that following the P-loop, the catalytic domain of SPAK contains four conserved hydrophobic residues that form a pocket which may interact with the P+1 residue of the substrate [10] .
As there are many phosphorylation steps in the pathway of NKCC1 activation, there must be many opposite dephosphorylation steps leading to co-transporter inactivation. Fortunately, there are far less serine/threonine phosphatases than serine/ threonine kinases. However, the details of NKCC1 dephosphorylation have not yet been fully elucidated. The co-transporter itself was shown to be a 'regulatory subunit' of PP1 as it contains a PP1-binding (RVxF) motif in its N-terminal cytosolic tail [60] . As expected, mutations of this motif affected co-transporter function. Intriguingly, this motif also overlaps with a SPAK/OSR1-binding motif, as the NKCC1 N-terminal tail sequence is GRFRVNF. Whether there is binding competition at the site between the kinase and phosphatase is still unknown. This possible interplay between the kinase and the phosphatase at the site should be thoroughly examined. In that respect, we observed that by overexpressing a protein that scaffolds both SPAK and PP1, we could drive the phosphorylation/dephosphorylation reaction towards co-transporter inactivation [61] . Indeed, overexpression in Xenopus laevis oocytes of a protein called AATYK, led to complete co-transporter inactivation. For this effect, the kinase activity of AATYK was not required. However, the binding of both SPAK and PP1 was needed, as mutation of either binding site would suppress the effect. Thus as dephosphorylation of NKCC1 constitutes an important step for NKCC1 de-activation, the dephosphorylation and de-activation of the regulatory kinase must also constitute a critical step. Further studies are clearly needed to clarify the modalities of phosphatase actions. K + -Cl − co-transport represents the second branch of CCCs. K + -Cl − co-transport promotes the electroneutral, coupled and Na + -independent movement of potassium together with chloride through four gene products, KCC1-KCC4. These transporters are also activated by a variety of stimuli, including cell swelling (for reviews see [62, 63] ), and are involved in epithelial transport [64] [65] [66] and chloride homoeostasis in neurons [67] [68] [69] . The role of SPAK and/or OSR1 in regulating K + -Cl − cotransport has received less attention. Although the original KCC2 cDNA does not contain a bona fide RFxV motif, yeast twohybrid analysis revealed that its N-terminus still interacts with the kinase. Whether the folding of the N-terminus creates an interacting site remains to be determined. In agreement with a possible interaction, using heterologous expression of KCC2 in Xenopus laevis oocytes, we showed a dominant-negative effect of SPAK on KCC2 function, as expression of kinase-dead SPAK significantly increased KCC2 activity to levels similar to those observed upon hypotonic stimulation [30] . Of interest, is the recent demonstration of another KCC2 isoform (KCC2a) with an alternative 5 start site which is encoded by a different promoter [70] . In contrast with the original isoform (KCC2b), this isoform contains a typical RFxV motif. Whether or not other KCCs are also regulated by SPAK is still a matter of debate. Furthermore, recent evidence suggests that KCC1, KCC3 and KCC4 might be regulated by WNK, independently of SPAK [71] .
Finally, as already introduced above, a relationship similar to that of SPAK and NKCC1 in mammals has been found in the nematode, C. elegans. GCK-3 (the worm orthologue of OSR1) binds to the C-terminal tail of CLH3, a cell-cycle-dependent CLC anion channel [19] . In contrast with SPAK and NKCC1, GCK-3 phosphorylation of CLH3 results in a substantial decrease in channel activity. Consistent with that effect, catalytically inactive kinase does not affect CLH3 function. Furthermore, mutation of the RFxI motif also resulted in the inability of GCK-3 to affect CLH3 function [19] . Recently, utilizing a promoter-driven GFP (green fluorescent protein) reporter, GCK-3 expression was demonstrated in the worm excretory cell, hypodermis, spermatheca, body wall muscle and nerve cord [29] . This new study also identified a single worm WNK, WNK-1, which physically interacts with GCK-3 in a common signalling cascade to modulate volume-sensitive transport pathways. Inactivation of either GCK-3 or WNK-1 by siRNA (small-interfering RNA) significantly affected the ability of the nematode to survive in a hypertonic environment [29] .
SPAK and OSR1 relationship to MAPK
A study reporting the cloning of the mouse SPAK cDNA also reported evidence for SPAK-specific activation of the p38 MAPK pathway [1] . Evidence was based on the ability of overexpressed wild-type, but not catalytically inactive, SPAK to activate p38, as measured through the ability of immunoprecipitated p38 to phosphorylate its substrate ATF2 (activating transcription factor 2).
Interestingly, a mutant lacking the C-terminal-interacting domain was also able to activate p38, suggesting that this effect does not necessitate SPAK binding through its regulatory C-terminus [1] . p38 MAPK activation by SPAK has also been demonstrated in the Caco2-BBE colonic cell line [11] , and in HEK (human embryonic kidney)-293 cells overexpressing the TNF receptor RELT (receptor expressed in lymphoid tissues) [18] . In this later case, overexpression of the TNF receptor also led to activation of the JNK (c-Jun N-terminal kinase) MAPK pathway. Activation of both p38 and JNK pathways was mediated by SPAK, as a SPAK binding-deficient mutant of the RELT receptor was unable to activate the MAPK pathways. Furthermore, kinase-dead SPAK also prevented activation of both p38 and JNK MAPKs [18] . All of these results suggest an additional function of SPAK, namely the activation of the MAPK pathway. As STE20p functions as a putative MAP4K, it is tempting to place SPAK and OSR1 in the MAPK signalling pathway upstream of MAP3Ks.
The relationship between SPAK and p38 is also of interest in the context of NKCC function. In the cortical thick ascending limb of Henle, a reduction in external chloride results in a signalling cascade that ultimately leads to the activation of the renin/angiotensin system. As the chloride delivery to the cortical thick ascending limb of Henle decreases as a function of reduced glomerular filtration, activation of the renin/angiotensin system results in increased constriction of the afferent arteriole of the glomerulus and thus increased glomerular filtration. This phenomenon is called the tubuloglomerular feedback mechanism [72] . Intriguingly in the context of the present review, a decrease in external chloride results in the activation of COX-2 (cyclo-oxygenase-2) expression in a p38-dependent manner. Furthermore, what may link this pathway to the NKCC is the observation that the p38-mediated activation of COX-2 can also be mimicked by inhibiting the co-transporter NKCC2 with bumetanide [73] . These observations suggest that SPAK might link a change in co-transporter activity to p38 stimulation.
SPAK has also been shown to participate in the stimulation of the transcription factors AP-1 (activator protein 1) and NF-κB (nuclear factor κB) in T-cells [74] . This activation is mediated by PKCθ (protein kinase Cθ ) which binds to the C-terminal domain of SPAK and phosphorylates the STE20 kinase. Phosphorylation occurs at a serine residue (Ser 321 , mouse sequence numbering) located towards the end of the catalytic domain of SPAK. In contrast with the mutation of Ser 383 , substitution of this residue to either an alanine residue or an aspartic acid residue prevents SPAK activation, as demonstrated through NKCC1 activation in Xenopus laevis oocytes (K.B.E. Gagnon and E. Delpire, unpublished work).
In a recent study, Cobb and coworkers [75] showed that the Drosophila orthologue of mammalian OSR1, fray, participates in the sorbitol activation of the JNK pathway in Drosophila S2 cells. Fray probably acts by activating MAP3K, leading to the stimulation of the MAP2K/MEK4 and MEK7, resulting in JNK activation. The activity of immunoprecipitated OSR1 was assayed for its level of autophosphorylation after HEK-293 cells were treated with sorbitol, NaCl, anisomycin, okadaic acid, serum, nocodazole, Taxol, hydrogen peroxide, phorbol ester and epidermal growth factor [75] . Only sorbitol induced a significant activation of OSR1. In contrast with the Drosophila kinase, mammalian OSR1 was ineffective in activating the JNK pathway. It also did not affect the p38, ERK2 and ERK5 pathways. Interestingly, OSR1 was shown to phosphorylate Thr 84 of another STE20 kinase, PAK1. As PAK1 is involved in cytoskeletal rearrangements, OSR1 phosphorylation of PAK1 might play a role in cytoskeletal rearrangements known to occur during osmotic challenges [76] . Interestingly, the interaction between OSR1 and PAK1 does not involve the interacting C-terminal domain, as PAK1 lacks a SPAK/OSR1-binding motif, and interaction between the two proteins was detected by yeast two-hybrid analysis in the absence of the OSR1 C-terminal domain [75] . Whether SPAK also interacts with PAK1 was not addressed in the study.
SPAK-and OSR1-knockout studies
Both SPAK-and OSR1-knockout mice have been created in our laboratory based on gene-trapping resources obtained from both the Wellcome Trust Sanger Institute (Hinxton, Cambridge, U.K.) and the MMRRC (Mutant Mouse Regional Resource Center, University of California, Davis, CA, U.S.A.). From the Sanger Institute, we obtained a 5 hprt library clone (clone MHPN27a17), which contains a 6890 bp genomic sequence from the SPAK gene, the tyrosinase minigene, the 5 end of the hprt drug-resistance gene cassette and the neomycin-resistance gene cassette. The 6890 bp genomic fragment contains the 110 bp exon 6 of the SPAK transcript. When the vector is insertionally targeted into the homologous locus, the entire region of homology is duplicated, leading to the duplication of exon 6 in the mutant gene. The presence of the 5 hprt sequence in the transcript disrupts the coding sequence of SPAK after exon 6 (see Figure 7) . From the MMRRC, we obtained a targeted embryonic stem cell clone (XH-180). As seen in Figure 7 , the gene-trap vector pGT11xf, randomly inserted inside intron 15-16 in the embryonic stem cell line (XH-180), disrupting the OSR1 transcript after exon 15. This disruption resulted in a truncated OSR1 protein which lacks the regulatory C-terminal domain of the kinase. Neither case are optimal targeting events: in the case of SPAK, the duplication heavily complicates the genotyping of the mutant mice, as the homozygous mice cannot be distinguished from heterozygote animals using a PCR-based strategy. In the case of OSR1, targeting at the 3 end of the protein conceivably results in the production of a shorter protein that might have dominant-negative effects. Disruption of the OSR1 gene results in embryonic lethality, as no living pup was ever delivered (E. Delpire, unpublished work). Based on lung development, some OSR1-knockout embryos were seen developing until embryonic stage e17.5. Whether or not the mutated transcript in embryos is stable and leads to expression of a partial OSR1 protein remains to be determined. In contrast with the OSR1-knockout mouse, disruption of the SPAK gene results in viable animals with no overt phenotype (E. Delpire, unpublished work). Whether the mice experience subtle defects or stress-induced defects remains to be determined. Although it was surprising to obtain a seemingly normal SPAK-knockout mouse and an embryonically lethal OSR1-knockout mouse, it does make logical sense based on the evolution of the two genes.
Similarily, inactivation of the Drosophila orthologue of OSR1, fray, also results in larvae lethality [77] . As with OSR1, lethality occurs during the last larvae cycle (third-instar larvae). During early development (first-instar larvae), fray null mutants develop localized bulges in the nerves. These swellings are associated with abnormal ensheathment of axons by glial cells. The fray phenotype could be reversed by expressing the rat cDNA encoding for SPAK [77] . The nerve phenotype of the Drosophila fray mutant is intriguing in light of the fact that disruption of KCC3, an interactor of SPAK/OSR1, also develops axonal and periaxonal swelling that leads to a peripheral nerve disorder [78, 79] . Although it is tempting to relate these two nerve-bulging defects, there are no results indicating a common pathway in the development of these nerve defects. 
CONCLUSIONS
Over the last five years, since our laboratory first described an interaction between SPAK/OSR1 and the CCC superfamily, there has been a flurry of scientific inquiry into the regulatory role of these STE20p-related kinases. Converging with an explosion of activity related to the genetic and physiological roles of WNKs in ion transport and its relationship to hypertension (for reviews see [80, 81] ), these SPAK and OSR1 studies are providing a much deeper understanding of how transport processes are regulated. As new biochemical and functional data are constantly emerging, bringing novel models as to how these kinases might regulate ion transport, we have attempted in the present review to lay out the current status of the field while identifying areas of investigation still needed. We have examined the distribution of these two STE20p-related kinases across the animal kingdom, highlighting the importance of their extreme C-terminus interacting domains. The divergent effect of the genetic knockout of SPAK and OSR1 in the mouse (no overt phenotype compared with embryonic lethality) suggests a greater developmental importance for the OSR1 protein, and perhaps a redundant homoeostatic role for the SPAK protein. The regulation of ion homoeostasis and volume control in mammalian cells involves, to some degree, the interaction of SPAK/OSR1, WNKs and ion transport mechanisms such as the CCCs. These ion transporter/kinase interactions are conserved throughout evolution, as described from roundworms to humans. Clearly the identification of SPAK, OSR1 and WNKs as players in the evolutionary well-conserved physiological process of osmoregulation has allowed a first close look at the interface between intracellular effectors and membrane ion transporters. There is no doubt that our current understanding will be challenged and refined after the identification of additional effectors that may or may not participate in the same SPAK, OSR1 and WNK pathway of regulation.
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